drugset / Trial / NCT01641315

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

NCT01641315

Completed 75 enrolled Queen Saovabha Memorial Institute
Non-randomizedParallel-groupSingle-blindPrevention

Summary

Reduced 4-dose intramuscular rabies vaccination schedule was announced by US-ACIP and WHO to be one of the post-exposure prophylaxis regimens. However, concurrent usage of this regimen with rabies immunoglobulin have never been studied in the aspect that the immunity level would above the protective level required by WHO (0.5 IU/ml) for at least a year period. This study would access this subject.

Timeline

Start
2015-09
Primary completion
2018-04
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabies vaccine Vaccine Intramuscular
Background Equine Rabies Immunoglobulin Protein / enzyme biologic 40 iu/kg

Indications